Volume 13, Issue 4, Pages (April 2006)

Slides:



Advertisements
Similar presentations
Volume 14, Issue 3, Pages (March 2007)
Advertisements

Volume 11, Issue 11, Pages (November 2004)
Volume 13, Issue 6, Pages (June 2006)
Volume 19, Issue 9, Pages (September 2012)
A Squalene Epoxidase Is Involved in Biosynthesis of Both the Antitumor Compound Clavaric Acid and Sterols in the Basidiomycete H. sublateritium  Ramiro.
Biosynthesis of the Antitumor Agent Chartreusin Involves the Oxidative Rearrangement of an Anthracyclic Polyketide  Zhongli Xu, Kathrin Jakobi, Katrin.
Volume 15, Issue 7, Pages (July 2008)
Daniel Chi-Hong Lin, Alan D Grossman  Cell 
Volume 20, Issue 10, Pages (October 2013)
Volume 15, Issue 2, Pages (February 2008)
Volume 17, Issue 4, Pages (April 2010)
Volume 17, Issue 4, Pages (April 2010)
Volume 20, Issue 6, Pages (June 2013)
Tandem Modifications of an Epoxyquinone C7N Pharmacophore
Volume 15, Issue 9, Pages (September 2008)
An FAD-Dependent Pyridine Nucleotide-Disulfide Oxidoreductase Is Involved in Disulfide Bond Formation in FK228 Anticancer Depsipeptide  Cheng Wang, Shane.
Mechanism of Thioesterase-Catalyzed Chain Release in the Biosynthesis of the Polyether Antibiotic Nanchangmycin  Tiangang Liu, Xin Lin, Xiufen Zhou, Zixin.
Biosynthesis of Actinorhodin and Related Antibiotics: Discovery of Alternative Routes for Quinone Formation Encoded in the act Gene Cluster  Susumu Okamoto,
Volume 9, Issue 6, Pages (June 2002)
Benjamin N. Mijts, Pyung Cheon Lee, Claudia Schmidt-Dannert 
Volume 19, Issue 2, Pages (February 2012)
Volume 14, Issue 5, Pages (May 2007)
Volume 10, Issue 5, Pages (May 2003)
A Revised Pathway Proposed for Staphylococcus aureus Wall Teichoic Acid Biosynthesis Based on In Vitro Reconstitution of the Intracellular Steps  Stephanie.
Volume 15, Issue 8, Pages (August 2008)
Volume 14, Issue 1, Pages (January 2007)
Elucidation of the Biosynthetic Gene Cluster and the Post-PKS Modification Mechanism for Fostriecin in Streptomyces pulveraceus  Rixiang Kong, Xuejiao.
Volume 19, Issue 3, Pages (March 2012)
Yit-Heng Chooi, Ralph Cacho, Yi Tang  Chemistry & Biology 
Volume 13, Issue 5, Pages (May 2006)
Volume 14, Issue 2, Pages (February 2007)
Liujie Huo, Shwan Rachid, Marc Stadler, Silke C. Wenzel, Rolf Müller 
Shiela E. Unkles, Vito Valiante, Derek J. Mattern, Axel A. Brakhage 
Sherry S. Lamb, Tejal Patel, Kalinka P. Koteva, Gerard D. Wright 
Volume 14, Issue 8, Pages (August 2007)
Volume 18, Issue 10, Pages (October 2011)
Volume 10, Issue 11, Pages (November 2003)
RAD51 is essential for L. donovani.
Volume 16, Issue 5, Pages (May 2009)
Volume 14, Issue 2, Pages (February 2007)
Volume 10, Issue 5, Pages (May 2003)
Volume 15, Issue 5, Pages (May 2008)
Volume 11, Issue 11, Pages (November 2004)
New Aminocoumarin Antibiotics Formed by a Combined Mutational and Chemoenzymatic Approach Utilizing the Carbamoyltransferase NovN  Hui Xu, Lutz Heide,
Volume 22, Issue 6, Pages (June 2015)
Volume 17, Issue 4, Pages (April 2010)
Markerless Mutations in the Myxothiazol Biosynthetic Gene Cluster
Volume 15, Issue 6, Pages (June 2008)
Volume 18, Issue 4, Pages (April 2011)
Volume 16, Issue 5, Pages (May 2009)
Characterization of the Biosynthetic Gene Cluster for Benzoxazole Antibiotics A33853 Reveals Unusual Assembly Logic  Meinan Lv, Junfeng Zhao, Zixin Deng,
Volume 11, Issue 3, Pages (March 2004)
Volume 11, Issue 12, Pages (December 2004)
Volume 24, Issue 2, Pages (February 2017)
Volume 10, Issue 4, Pages (April 2003)
Biosynthetic Pathway Connects Cryptic Ribosomally Synthesized Posttranslationally Modified Peptide Genes with Pyrroloquinoline Alkaloids  Peter A. Jordan,
Dual Carbamoylations on the Polyketide and Glycosyl Moiety by Asm21 Result in Extended Ansamitocin Biosynthesis  Yan Li, Peiji Zhao, Qianjin Kang, Juan.
Volume 19, Issue 3, Pages (March 2012)
Volume 14, Issue 3, Pages (March 2007)
Sugar Receptors in Drosophila
Beyond Homing: Competition between Intron Endonucleases Confers a Selective Advantage on Flanking Genetic Markers  Heidi Goodrich-Blair, David A Shub 
Volume 13, Issue 7, Pages (July 2006)
Cloning, Heterologous Expression, and Characterization of the Gene Cluster Required for Gougerotin Biosynthesis  Guoqing Niu, Lei Li, Junhong Wei, Huarong.
Volume 15, Issue 7, Pages (July 2008)
Volume 12, Issue 3, Pages (March 2005)
Biosynthesis of the Antitumor Chromomycin A3 in Streptomyces griseus
Volume 14, Issue 9, Pages (September 2007)
Volume 12, Issue 3, Pages (March 2005)
A One-Pot Chemoenzymatic Synthesis for the Universal Precursor of Antidiabetes and Antiviral Bis-Indolylquinones  Patrick Schneider, Monika Weber, Karen.
Volume 22, Issue 6, Pages (June 2015)
Presentation transcript:

Volume 13, Issue 4, Pages 387-397 (April 2006) Functional Analysis of the Validamycin Biosynthetic Gene Cluster and Engineered Production of Validoxylamine A  Linquan Bai, Lei Li, Hui Xu, Kazuyuki Minagawa, Yi Yu, Yirong Zhang, Xiufen Zhou, Heinz G. Floss, Taifo Mahmud, Zixin Deng  Chemistry & Biology  Volume 13, Issue 4, Pages 387-397 (April 2006) DOI: 10.1016/j.chembiol.2006.02.002 Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 1 Valienamine-Containing C7N Aminocyclitols and Proposed Biosynthetic Pathways to VAL-A and Acarbose (Top) Chemical structures of VAL-A, acarbose, and pyralomicin 1a. Dashed-boxed regions show the cyclitol moiety shared by all three compounds. (Bottom) Previously proposed biosynthetic pathways to VAL-A [8] and acarbose [13, 14]. Chemistry & Biology 2006 13, 387-397DOI: (10.1016/j.chembiol.2006.02.002) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 2 Cloning Strategy for Sequencing and Genetic Organization of val Gene Cluster (A) Cloning strategy for sequencing of the 45 kb region. B, BamHI; C, ClaI; E, EcoRI. (B) Genetic organization of the val gene cluster. Genes proposed to be involved in validamycin biosynthesis are represented as black arrows. The previously sequenced 6.0 kb BamHI fragment was indicated by double-arrowed line. Chemistry & Biology 2006 13, 387-397DOI: (10.1016/j.chembiol.2006.02.002) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 3 Heterologous Production of Validoxylamine A and VAL-A (A) Reassembly of valABCKLMN and MS analysis (MS1). PermE∗, the upmutated promoter of the erythromycin resistance gene; E, EcoRI. Fragmentation of validoxylamine A (m/z 336.1) yields validamine (m/z 178.1) (MS2). (B) Coexpression of valABCKLMN and valG and MS detection (MS1). Fragmentation of VAL-A (m/z 498.2) generates validoxylamine A (m/z 336.1) and validamine (m/z 178.1) (MS2). Chemistry & Biology 2006 13, 387-397DOI: (10.1016/j.chembiol.2006.02.002) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 4 Inactivation and Complementation of Glycosyltransferase valG (A) Schematic representation of the replacement of an 806 bp internal fragment of valG with the 1.4 kb aac(3)IV. In shuttle plasmid pJTU609, aac(3)IV was inserted between the 2.4 kb and 1.0 kb genomic fragments originally flanking the deleted 806 bp region. While wild-type S. hygroscopicus should give a 2.1 kb PCR-amplified product, mutant LL-1 should yield a 1.5 kb product by using a pair of primers, ValG2-F and ValG2-R. (B) PCR analysis of wild-type S. hygroscopicus and mutant LL-1. (C) Bioassay comparison between the wild-type (left), LL-1 (middle), and LL-101 (right). LL-101 is the derivative of LL-1 harboring shuttle plasmid pJTU612 with valG. (D) HPLC profiles of the standards, wild-type, LL-1, and LL-101. The retention time of VAL-A is 9.7 min, and that of validoxylamine A is 6.5 min. Chemistry & Biology 2006 13, 387-397DOI: (10.1016/j.chembiol.2006.02.002) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 5 Heterologous Expression of valG and Characterization of the Glycosyltransferase (A) SDS-PAGE analysis of ValG protein: (1) molecular weight marker; (2) soluble protein of extract of E. coli BL21Gold(DE3)pLysS/valG before induction; (3) total protein of extract of E. coli BL21Gold(DE3)pLysS/valG after induction with IPTG; (4) soluble protein of line 3; (5) purified his-tagged ValG. (B) TLC analysis of ValG reaction (silica gel, solvent system: nPrOH:AcOH:H2O = 4:1:1); R, validoxylamine A standard; U, ValG reaction by using UDP-glucose as glucosyl donor, G, ValG reaction by using GDP-glucose as glucosyl donor; A, ValG reaction by using ADP-glucose as glucosyl donor; T, ValG reaction using TDP-glucose as glucosyl donor. (C) Conversion scheme of validoxylamine A to VAL-A catalyzed by ValG. Chemistry & Biology 2006 13, 387-397DOI: (10.1016/j.chembiol.2006.02.002) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 6 Proposed Biosynthetic Pathway to VAL-A Chemistry & Biology 2006 13, 387-397DOI: (10.1016/j.chembiol.2006.02.002) Copyright © 2006 Elsevier Ltd Terms and Conditions